GLYCODRAW-FB

MRP

MRP 974/-UNIT

Description

Each Actuation Delives : Glycopyrrolate IP 9.0mcg + Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 4.8 mcg + Budesonide IP 160mg Suspended In Propellant HFA 134a q.s.

Doses

• As directed by the Physican

Indication

• Glycodraw FB Inhaler is a combination of three medicines. It is used in the treatment of chronic obstructive pulmonary disease (COPD).